Neumora Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMRA and other ETFs, options, and stocks.About NMRA
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience.
CEOPaul L. Berns
CEOPaul L. Berns
Employees110
Employees110
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2019
Founded2019
Employees110
Employees110
NMRA Key Statistics
Market cap314.46M
Market cap314.46M
Price-Earnings ratio-1.34
Price-Earnings ratio-1.34
Dividend yield—
Dividend yield—
Average volume862.17K
Average volume862.17K
High today$1.96
High today$1.96
Low today$1.83
Low today$1.83
Open price$1.95
Open price$1.95
Volume689.46K
Volume689.46K
52 Week high$11.57
52 Week high$11.57
52 Week low$0.611
52 Week low$0.611
Stock Snapshot
The current Neumora Therapeutics(NMRA) stock price is $1.88, with a market capitalization of 314.46M. The stock trades at a price-to-earnings (P/E) ratio of -1.34.
On 2025-12-16, Neumora Therapeutics(NMRA) stock moved within a range of $1.83 to $1.96. With shares now at $1.88, the stock is trading +2.8% above its intraday low and -4.0% below the session's peak.
Trading volume for Neumora Therapeutics(NMRA) stock has reached 689.46K, versus its average volume of 862.17K.
Over the past 52 weeks, Neumora Therapeutics(NMRA) stock has traded between a high of $11.57 and a low of $0.61.
Over the past 52 weeks, Neumora Therapeutics(NMRA) stock has traded between a high of $11.57 and a low of $0.61.
Analyst ratings
63%
of 8 ratingsBuy
62.5%
Hold
25%
Sell
12.5%
People also own
Based on the portfolios of people who own NMRA. This list is generated using Robinhood data, and it’s not a recommendation.